Faes Farma stock

FAE · BME · EUR

Compare Faes Farma
€5.01Change from previous close: −1.38%Absolute change: −€0.07

Close · November 17, 2026

Price history

+8.89% over the period

1 year: from €4.61 (November 17, 2025) to €5.02 (November 17, 2026), +8.89%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026€5.02
October 30, 2026€4.82
September 30, 2026€4.66
August 31, 2026€4.51
July 31, 2026€4.56
June 30, 2026€4.59
May 29, 2026€4.66
April 30, 2026€4.86
March 31, 2026€4.66
February 27, 2026€5.20
January 30, 2026€5.23
December 31, 2025€5.16
November 28, 2025€4.76
November 17, 2025€4.61

At a glance

  • The company

    Researches, develops, produces and markets pharmaceutical products, healthcare specialties, animal nutrition products and pharmaceutical raw materials

  • Latest results

    Quarter to September 30, 2026 · EPS €0.05

TickerLandia's take on Faes Farma

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€4.32
52-wk high€5.44

−7.90% from the 52-week high

Analysts · 5 analysts

Average target€5.56+11.06% vs. price

Buy 3 · Hold 2 · Sell 0 · Buy

TickerLandia Fingerprint: Faes Farma

Compared with similar companies: high dividend, low risk, and low price.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Faes Farma is pricier than in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Faes Farma's P/E today is 19.8, above the median of its last 10 fiscal years (14.1; between 9.78 and 22.3 from 2016 to 2025). Faes Farma's P/E (trailing 12 months): 18.7, in line with the median of a group of 10 similar companies (19.0).

P/E compared with its history

Compared with 10 similar companies

Faes Farma's metrics compared with similar companies
MetricFaes FarmaPosition in the groupBand
P/E (trailing 12 months)18.7Middle
Forward P/E14.6Middle
Operating margin13.0%Low
ROE11.2%Middle
Debt/equity0.58Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Faes Farma. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€172.08M

Latest quarter · Q3 2026

Net income

€17.25M

Latest quarter · Q3 2026

Quarterly net margin

10.0%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
€1.58B
P/E
18.7
EPS
€0.27
Volume
211.69K
Daily trading
€684.45K
Dividend yield
2.55%
Last ex-dividend on July 2, 2026

How Faes Farma is changing

All results
  • Revenue grew 8.8% a year on average over the last 5 years

  • Operating margin fell from 22.1% to 14.2%

  • Less cash than profit: free cash flow equal to 53% of net income

Returns

Faes Farma returns with dividends

€1,000 invested in Faes Farma 5 years ago, on November 17, 2021, would be worth €1,888 today with dividends reinvested: +88.81% in total, +13.56% per year. On price alone it would be €1,495 (+49.54%).

PeriodFaes FarmaIBEX 35€1,000 becomes
1 month+7.26%+3.21%€1,073
6 months+9.03%+13.19%€1,090
Year to date−2.71%+15.25%€973
1 year+11.78%+23.34%€1,118
3 years+84.93%+104.34%€1,849
5 years+88.81%+121.79%€1,888
10 years+139.08%+128.80%€2,391

Over the last 6 months it has done better than 19% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. IBEX 35: price only. Calculate your investment

The chart in detail

Faes Farma: technical analysis

Faes Farma shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 72.0% below its all-time closing high (€17.86, March 29, 2007).

Trend
No clear trend
RSI (14 sessions)
62
Between 30 and 70
vs 200-session average
+6.74%

Active signals

  • Golden cross: the 50-session average has crossed above the 200-session average.

    since November 11, 2026

Support and resistance

Price areas where Faes Farma has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€5.42+8.18%2 touches, last on February 13, 2026
  2. Resistance€5.18+3.29%2 touches, last on February 27, 2026
  3. Last price€5.01
  4. Support€5.00−0.20%3 touches, last on October 15, 2026
  5. Support€4.79−4.32%4 touches, last on September 29, 2026
  6. Support€4.69−6.39%2 touches, last on July 2, 2026

Volatility and risk

Over the last year it has moved less than the IBEX 35.

Beta (1 year) vs IBEX 35
0.48
Volatility (60 sessions, annualised)
21.9%
Largest fall in the last year
−19.24%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Faes Farma: seasonality

Average monthly price change over 27 years

+5.6%Jan+3.0%Feb+0.0%Mar+1.7%Apr−2.0%May−1.6%Jun−0.7%Jul−0.2%Aug−0.2%Sep+0.9%Oct+0.8%Nov−2.4%Dec

Over the last 27 years, the strongest month for Faes Farma has been January: +5.60% on average, positive in 18 years out of 26. The weakest has been December: −2.41% on average, positive in 9 years out of 26. November, the current month, has been positive in 16 years out of 26 (+0.78% on average).

Show chart data
MonthAverageMedianPositive years
January+5.60%+5.27%18 of 26
February+3.00%−0.11%13 of 27
March+0.02%−0.41%12 of 27
April+1.69%+4.30%15 of 27
May−1.95%−2.12%9 of 27
June−1.63%−0.80%11 of 27
July−0.67%−0.94%11 of 27
August−0.23%0.00%13 of 27
September−0.17%−0.25%12 of 27
October+0.89%+2.06%15 of 27
November+0.78%+2.54%16 of 26
December−2.41%−2.03%9 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Faes Farma and its competitors

Prescription and healthcare products, along with the raw materials used to make them, form the core of Faes Farma's activity, and the company sells them internationally. Its medicines cover several therapeutic areas, while a separate line supplies nutrition and health products for animals. The group also engages in chemical products, foodstuffs, cosmetics and dietetics services. Founded in 1933, it holds patents, trademarks, registered brands and equity interests, and it invests in securities and real estate.

Headquarters
Leioa, Spain
Employees
2,677
Founded
1933
Chief executive
Eduardo de la Cuadra
Faes Farma and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Faes FarmaFAE$1.73B13.0%18.7+9.03%
FagronFAGR$1.9B14.3%18.8+0.21%
AlmirallALM$2.53B9.6%32.1−7.24%
PharmaNutraPHN$875.44M21.7%35.0−3.45%
Siegfried HoldingSFZN$3.53B16.7%17.3−14.20%
Laboratorios Farmaceuticos RoviROVI$3.93B20.2%17.4+16.20%

Same industry or related industries, similar size. Compare Faes Farma with its competitors · Full profile